Highbridge Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-55,642
Closed -$9.84M 896
2018
Q1
$9.49M Buy
+55,642
New +$10.2M 0.15% 158
2017
Q2
Sell
-52,944
Closed -$8.61M 1217
2017
Q1
$8.69M Sell
52,944
-97,068
-65% -$16.1M 0.13% 210
2016
Q4
$21.9M Buy
150,012
+144,243
+2,500% +$21.7M 0.39% 72
2016
Q3
$962K Sell
5,769
-21,955
-79% -$3.71M 0.02% 581
2016
Q2
$4.22M Buy
27,724
+23,887
+623% +$3.71M 0.07% 288
2016
Q1
$575K Sell
3,837
-2,345
-38% -$348K 0.01% 929
2015
Q4
$1M Sell
6,182
-129,463
-95% -$20.3M 0.02% 753
2015
Q3
$18.8M Buy
135,645
+36,177
+36% +$5.7M 0.29% 85
2015
Q2
$15.3M Sell
99,468
-129,036
-56% -$20.7M 0.19% 135
2015
Q1
$36.5M Buy
228,504
+174,507
+323% +$27.5M 0.5% 43
2014
Q4
$8.6M Sell
53,997
-10,154
-16% -$1.58M 0.11% 231
2014
Q3
$9.01M Sell
64,151
-77,971
-55% -$10.2M 0.12% 215
2014
Q2
$16.8M Buy
+142,122
New +$16.5M 0.2% 129
2014
Q1
Sell
-139,312
Closed -$16.9M 1027
2013
Q4
$15.9M Sell
139,312
-247,019
-64% -$28.1M 0.19% 152
2013
Q3
$43.2M Buy
386,331
+23,707
+7% +$2.57M 0.46% 47
2013
Q2
$35.8M Buy
+362,624
New +$37.6M 0.36% 63

Other funds holding AMGN

Highbridge Capital Management's AMGN Position: Q2 2018 in Review

Highbridge Capital Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 55,642 shares — an estimated $9.84M sold.

Highbridge Capital Management first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $43.2M in Q3 2013. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Highbridge Capital Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 55,642 Amgen shares in Q2 2018, an estimated $9.84M.
  • Highbridge Capital Management first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
  • Highbridge Capital Management's Amgen position peaked at $43.2M in Q3 2013.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.